Intellia Therapeutics, Inc. (NTLA): Total Assets
$842.13M
As of 2025-12-31
$857.16M
As of 2026-06-30
-17.9%
3-year compound annual growth
+4.5%
5-year compound annual growth
+26.2%
10-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $842.13M | -29.3% | 2026-02-26, Balance as of period end |
| 2024-12-31 | $1.19B | -8.5% | 2026-02-26, Balance as of period end |
| 2023-12-31 | $1.30B | -14.4% | 2025-02-27, Balance as of period end |
| 2022-12-31 | $1.52B | +17.4% | 2024-02-22, Balance as of period end |
| 2021-12-31 | $1.29B | +91.4% | 2023-02-23, Balance as of period end |
| 2020-12-31 | $676.32M | +102.3% | 2022-02-24, Balance as of period end |
| 2019-12-31 | $334.28M | -3.8% | 2021-02-26, Balance as of period end |
| 2018-12-31 | $347.31M | -7.7% | 2020-02-27, Balance as of period end |
| 2017-12-31 | $376.24M | +25.8% | 2019-02-27, Balance as of period end |
| 2016-12-31 | $298.97M | +264.0% | 2018-03-14, Balance as of period end |
| 2015-12-31 | $82.14M | n/a | 2017-03-14, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Intellia Therapeutics, Inc. (NTLA) | 2025-12-31 | $842.13M | -29.3% |
| Alpha Teknova, Inc. (TKNO) | 2025-12-31 | $103.58M | -12.8% |
| Immucell Corp (ICCC) | 2025-12-31 | $42.53M | -5.7% |
| Aspira Women's Health Inc. (AWHL) | 2025-12-31 | $5.46M | -0.6% |
| Anbio Biotechnology (NNNN) | 2025-12-31 | $30.24M | +59.8% |
| Myriad Genetics Inc (MYGN) | 2025-12-31 | $706.60M | -31.2% |
| Neogen Corp (NEOG) | 2026-05-31 | $3.35B | -2.8% |
| Biomerica Inc (BMRA) | 2026-05-31 | $6.76M | +13.7% |
| Insight Molecular Diagnostics Inc. (IMDX) | 2025-12-31 | $25.76M | -26.6% |
Compare NTLA, TKNO, ICCC, AWHL side by side · Screen every company in In Vitro & In Vivo Diagnostic Substances ↗